This Conference, the first of its kind in Europe, will examine how nanotechnology could contribute to alternatives to animal testing and also to realisation of the "3Rs”, whilst maintaining the necessary high levels of safety in the pharmaceutical, medical device, chemical, cosmetic and environmental industries.
At this event, leading international experts will
- review some of the most promising new, human cell-based in vitro models
- describe novel lab-on-a-chip and bioreactor systems for screening, and for toxicological and targeting studies
- examine how understanding of the behaviour of materials at the nanoscale can be used to improve biosensors and diagnostic systems
- consider new paradigms for applying alternatives incorporating nanotechnology
At this event, leading international experts will
- review some of the most promising new, human cell-based in vitro models
- describe novel lab-on-a-chip and bioreactor systems for screening, and for toxicological and targeting studies
- examine how understanding of the behaviour of materials at the nanoscale can be used to improve biosensors and diagnostic systems
- consider new paradigms for applying alternatives incorporating nanotechnology
